chrisvoncsefalvay/vaers-outcomes huggingface dataset:
chills & fever, local rxn, & swollen gland; tx w/ATB; On same day as inj did fell & hit arm also; 5JUL94 feeling better & swelling dec; had DTP 10yrs ago; 9AUG94 f/u recovered;
Bruising noted to (L) arm 22 cm x 11 cm. Pt denies pain or warmth to (L) arm.
SKIN PROBLEM; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request batch/lot number. No concomitant medications were reported. On an unspecified date, the patient experienced skin problem. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of skin problem was not reported. This report was non-serious.
Got vaccine and got shingles/suspected vaccination failure; Shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles (got years ago). Previously administered products included Shingles vaccine with an associated reaction of herpes zoster (received on an unknown date and had symptom of a shingles on back very painful).   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (Verbatim: Got vaccine and got shingles/suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: Shingles). The patient was treated with lidocaine (Lidocaine Patch). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.     It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.   Additional Information: GSK Receipt Date: 08-MAR-2023 This case was reported by a patient via interactive digital media. The patient reported that he/she had shingles and then he/she received one shot shingles vaccine that was available and then experienced shingles on back which was very painful. The patient went for the two dose Shingles vaccine and thought that it would prevent it. The patient again experienced Shingles four more times. The patient stated that the physician gave him/her shingles cram and lidocaine patches as a treatment. The patient stated that cannot stress enough get vaccine before you get shingles. Follow-up would not possible as no contact details were available.
Pt came to pharmacy on the evening of  1/27/20 complained left shoulder pain that it's difficult for him to put on his shirt. He stated he didn't have any fever, swelling, or any side effects after the injection.  The pain appeared 1 week after the vaccination and persists till now.  Pt dd not take any medication for the symptom. Pt will see his primary care soon.  Advised pt to take Aleve with food.
Patient received 2nd Moderna vaccine on 03/15/2021. Tested positive for Covid-19 on 08/26/2021.
Pt. stated that she received the COVID vaccine on 1/20/21.  On 1/21/21 she felt tired, had loss of appetite.  She reported that she went to a store, and apparently "passed out."  Employees of the store told her that she had a seizure.  Pt. was transported to local ER, where she states that she had a CT of brain, blood work and was told "everything is normal." Stated that she had COVID testing both in the ER and at work, both reportedly negative.  This clinic, has thus far been unable to obtain the individuals medical records from the ER.  When seen in our clinic on 2/3/21, pt. stated that she is feeling better, but fatigued.  No other loss of consciousness reported by pt.
This spontaneous report was received from a physician, via company representatives and from a support services director, concerning to a patient of unknown age and gender. Information regarding medical history, concurrent conditions and concomitant medications was not provided. On 13-OCT-2015 the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 10 single Ds 0.5 ml 10 Vls SDV (lot number and expiration date: K007262 and 25-NOV-2015 respectively; route of administration was not provided). The vaccine had an excursion of 34 degrees Fahrenheit (1.111111111 degrees Celsius) (lowest recorded temperature) for 216 hours (sum of hours in excursion). The vaccine status was reported as "in excursion". The vaccine storage criteria and type were reported as "refrigerator (R)". No adverse events were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Patient received COVID-19 vaccination (Moderna) at 11:54 A.M.; she arrived in the observation unit and began having difficulty breathing and swallowing at 11:58 A.M.. Epi Pen (0.3 mL) was administered at 12:00 P.M. in the left lateral thigh.  Patient received Benadryl IM (1 mL) at 12:05 P.M.  in the left upper arm. At 12:10 patient said that throat tightening was beginning to subside. 911 was called and EMS was dispatched to the Brighton Health Center. Patient is being taken to the University hospital emergency department.     Vitals: 12:05--O2 96%; HR 102 bpm   12:10--O2 98%; HR 107 bpm; BP 160/93 mm Hg (sitting)
RECEIVED VACCINES ON 3/27/07. PRESENTED ON 4/5/07 WITH A 2 DAY HISTORY OF HIGH GRADE FEVER (104.1).  ALSO REPORTED 1 LOOSE STOOL AND SOME COUGH. OTHERWISE WELL.
Feverish, extreme fatigue, flu like symptoms, body aches and pains, severe pain on left arm, joint pain, stomach pain, weakness, severe headaches, nausea. Began at 1am the next morning, I woke up due to the severity of the symptoms.
tender, swollen lymph nodes left clavicle area noticed 5 days following injection 1/5/21 only experienced sore lt arm 1st 24 hrs of injection
Woke up itching all over my bodice, face, and neck.  Went to bathroom & discovered rash.  Took Benadryl for the next 24 hours.  Lasted approximately 2-3 days.  Had headache for five days which did not respond to normal treatment.
Pt was given Moderna Sars vaccine. Initially he told the MA that he had not ever received a Covid vaccine. After she injected the Moderna dose he remembered that he had received a first dose. The MA checked Immtrac and discovered he had received the Pfizer Covid vaccine on 4/29/21. lot #EW0176.
Severe chills, pain around the trunk, difficulty breathing due to severe pain, unable to feel warm even though I was in bed with a very heavy down quilt and an electrically heated mattress pad turned up all the way.  Symptoms lasted about 2 hours.
right cheek numb, left cheek numb, front neck numbness. Right arm injection site, still has pain with movement. Right arm , mid spine and right leg intermittent paresthesias. Brain fog
The headache was present after the first dose; This is a spontaneous report from a contactable consumer (patient self-reported). A 30-year-old female patient (who was not pregnant at the time of vaccination) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: EL3247, expiry date not provided) via an unspecified route of administration, in arm left, on 29Jan2021 12:15, as single dose for COVID-19 immunisation, at workplace clinic. The patient medical history was not reported. The patient concomitant medication included Ibuprofen (ADVIL). Patient had no Allergies to medications, food, or other products. Patient was not diagnosed with COVID-19, prior to vaccination. Since the vaccination, patient has not been tested for COVID-19. It was reported that the headache was present after the first dose on an unknown date in Jan2021. No treatment was received by patient for headache. Seriousness of the events was reported as non-serious. The outcome of the event was recovered on an unknown date in Feb2021.
Pain at injection site; headache; muscle pain; chills; joint pain; tiredness; fever; nausea; This is a spontaneous report from a contactable healthcare professional (patient). A 43-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) (lot number/expiration date: not provided), via intramuscular route of administration, on 28Dec2020 at 09:15 AM (at the age of 43 years old) as a single dose in the right arm for COVID-19 immunization. Relevant medical history was none. The patient did not have any known allergies to medications, food, or other products. Prior to the vaccination, it was unknown if the patient was diagnosed with COVID-19. Concomitant medication were not provided. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 28Dec2020, at 11:30 PM, the patient experienced pain at injection site, headache, muscle pain, chills, joint pain, fever, tiredness and nausea. No treatment was received for the events pain at injection site, headache, muscle pain, chills, joint pain, fever, tiredness and nausea. The outcome of the events pain at injection site, headache, muscle pain, chills, joint pain, fever, tiredness and nausea was recovered on an unspecified date in Dec2020. Since the vaccination, the patient had not been tested for COVID-19.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Redness, swelling, rash to injection site on 9/28/2020.   Benadryl given to patient.     On 9/29/2020  redness, swelling  to injection site,  hives to body.    Patient was seen in urgent care and instructed to continue Benadryl for the next few days.  No hives present today.
NUMBNESS IN LEFT ARM FROM SHOULDER DOWN TO FINDERS AND IN BOTH LEGS; SWOLLEN RIGHT FOOT 2X BIGGER; LOSS OF COORDINATION; HARD TO WALK; LITTLE FEVER; This spontaneous report received from a patient concerned a 47 year old male. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient had no history of diabetes except family history.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805018, and batch number: 1805018 expiry: UNKNOWN) dose was not reported, administered on 01-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 01-APR-2021, the subject experienced little fever. On 15-APR-2021, the subject experienced numbness in left arm from shoulder down to finders and in both legs. On 15-APR-2021, the subject experienced swollen right foot 2x bigger. On 15-APR-2021, the subject experienced loss of coordination. On 15-APR-2021, the subject experienced hard to walk. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from little fever on 03-APR-2021, and had not recovered from numbness in left arm from shoulder down to finders and in both legs, swollen right foot 2x bigger, loss of coordination, and hard to walk. This report was non-serious.
dizziness and chest pain. I am well hydrated and constantly feel dizziness and some chest pain. I also miscarried 6 months after receiving the 2nd dose of the pfizer vaccine last year. this vaccine is not 100% safe.
rash developed at the injection site with some swelling.; rash developed at the injection site; This case was reported by a consumer via call center representative and described the occurrence of injection site swelling in a 66-year-old female patient who received Herpes zoster (Shingrix) (batch number C47FY, expiry date 16th September 2022) for prophylaxis.   On 28th August 2020, the patient received the 1st dose of Shingrix (intramuscular). On 28th August 2020, less than a day after receiving Shingrix, the patient experienced injection site swelling and injection site rash. On an unknown date, the outcome of the injection site swelling and injection site rash were unknown.   It was unknown if the reporter considered the injection site swelling and injection site rash to be related to Shingrix.  Additional details were provided as follows: After receiving Shingrix, the patient experienced rash at the injection site with some swelling. The reporter did not consent to follow up.
Metallic taste in mouth, tingly feeling in tongue.  Started about an hour or two after receiving the vaccine and lasted for roughly 24 hours.
1 of 4 pts vaxed from the same vial who had an adverse event;pt exp erythema & swelling from the shoulder to elbow of vaxed arm;seen by MD no cultures done;no ATB administered;
(L) arm with 10x11 cm area erythema with induration and tenderness in upper arm. (and bruise in lower arm).
Arm is very swollen; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Arm is very swollen) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 22-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (Arm is very swollen). At the time of the report, PERIPHERAL SWELLING (Arm is very swollen) outcome was unknown.            No concomitant medication was reported. No Treatment information was reported.
Beginning day 5 post vaccination fever x 2 days, Day 7 major take recorded, Day 9 swelling, erythema, 10 cm in size a site with lymphangitis into right underarm. Rest and anti inflammatories, fever. Day 10 decreased swelling, erythema.
pt recv vax 4NOV98 & 5NOV98 pt exp erythema, warmth, & tenderness @ the inj site, & fever of 102;inj site rxn wax 8x9cm in diameter & was quite hard;Md visit required;given md;walked w/limp d/t inj site rxn;somewhat disabled;
The injection site swollen; The injection site red; Raised up below the injection site; Soreness in arm/more tender; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Soreness in arm/more tender), VACCINATION SITE SWELLING (The injection site swollen), VACCINATION SITE ERYTHEMA (The injection site red) and VACCINATION SITE INDURATION (Raised up below the injection site) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037K20A and 043620A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No prior medical history reported.). Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), VITAMIN C [ASCORBIC ACID], CALCIUM and ATORVASTATIN CALCIUM, EZETIMIBE (STATIN EZ) for an unknown indication.   On 29-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Jan-2021 at 5:00 PM, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Jan-2021, the patient experienced VACCINATION SITE PAIN (Soreness in arm/more tender). On 27-Jan-2021, the patient experienced VACCINATION SITE SWELLING (The injection site swollen), VACCINATION SITE ERYTHEMA (The injection site red) and VACCINATION SITE INDURATION (Raised up below the injection site). At the time of the report, VACCINATION SITE PAIN (Soreness in arm/more tender), VACCINATION SITE SWELLING (The injection site swollen), VACCINATION SITE ERYTHEMA (The injection site red) and VACCINATION SITE INDURATION (Raised up below the injection site) had not resolved. Not provided.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   Reporter did not allow further contact
patient developed redness, swelling, pain on right arm only about 11 PM on 4/18/19.  (Of note, on 1/30/14, she had Prevnar, Menactra and Hib and had no reaction. On  3/31/14, she had  Pneumovax  and Menactra at a local MD's office, administered in same arm,  and she had a considerable local reaction to the  vaccines  with an ensuing  possible strep infection resulting in a hospital admission/IV antibiotics.  This was not seen by this writer, but well described by patient .)
Patient presented with five days of leg achiness, progressive upper and lower extremity weakness, areflexia, diagnosed with Guillain Barre Syndrome.  Sensory symptoms first onset several weeks prior.
The morning after my covid booster shot (3rd dose of Pfizer vaccine) I woke up with a very swollen ankle and leg on the side of my body that the vaccine was injected into. It has been 5 days now and the swelling has not gone down and my leg hurts more. There is a pain that goes up my leg to my knee and up to my thigh. It is all swollen and sometimes feels numb and tingly.  I have a lot of discomfort walking.  The swollen ankle is probably 2-3X  as big as the other ankle and really hurts.
9 days p/vax devel fever 105 & a rash;sx lasted 2 days;MD determined it was a rxn to vax;
The day after the vaccination, at 10:00am, I began feeling poorly.  I was fatigued, developed a fever, had chills, cough, runny nose, watery eyes,  body aches, shortness of breath, headaches, loss of appetite, brain fog..  Slept 16 hours that night through the following day.  Still felt bad, but could eat.  Symptoms were still present but decreased in severity.  Maintained a headache for four days.  Arm at injection site is still hurting (tender to the touch) and swollen.  Symptom free by 4/5/2021 except for arm being sore and tender.  Previously had virus in July 2020.  Felt like all the same symptoms including a few new ones.  Did not go to doctor.
Went to ED 3/30/21  Immediately after receiving the second vaccine 2/25 he developed chest tightness and joint pain. The chest tightness resolved within a few hours. He then had severe fatigue x36 hours-sleeping most of that time?followed by fever, chills, myalgias x2d. Those resolved but the arthralgias have persisted since then. Within 1 week he developed worsened joint hypermobility and has had multiple subluxations (fingers, ankles, knee, elbow) that has persisted. Within 1 week he developed joint swelling. He had diffuse pain and hyperalgesia with pain to minimal pressure. At 2 weeks he developed a pruritic popular rash on LE. Due to joint swelling and rash he was placed on a 5d prednisone burst that decreased the pain, swelling, and rash, but recurred when prednisone d/c?d. He was restarted on a 2 week taper which helped partially with pain and swelling but did not resolve them and the rash continued to spread. He still has the rash present now diffuse on legs and torso but it seems to have stopped spreading as of this week. The joint swelling has also seemed to plateau but has not resolved. The joint pain and worsened hypermobility is slowly improving but not resolved. 2 weeks ago (4 weeks after vaccine) he developed new neuropathic symptoms?tingling in his extremities with intermittent shock-like pain, followed by itching and burning along S2-S3 dermatomes (into groin) and back pain. The sacral sxs resolved w/in 1 week but the tingling in extremities has persisted.
Within 12 hrs site appeared red/raised and sore, 1'st day after rec'd site appeared with lg red welt, about 3-4 cm diameter, and red and hardened and sore. Very hot to touch; more to 4 cm size. 3'rd day remained with lg. welt and hard. 4th day just red and softer. Took ADVIL from 2nd day on (06 hrs) (600 mg) applied hydrocortisone and cold compress to site PRN. Also ran low grade fever approximately 100.2 first 2 days.
Chills; fatigue; decay; This is a spontaneous report from a contactable consumer or other non hcp (patient herself). A 38-year-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection), dose 1 via an unspecified route of administration, administered in Arm Right on 07Apr2021 20:00 (at the age of 38 years old) (Batch/Lot number was not reported) as single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient has no known allergies to medications, food, or other products. No other vaccine was administered in four weeks and no other medication within two weeks prior to vaccination. On 07Apr2021 21:00, the patient experienced chills, fatigue, decay. No treatment was received for the adverse events. The patient has not been diagnosed with COVID-19 prior to vaccination and has not been tested for COVID-19 post vaccination. The outcome of the events was recovering.  Information about lot/batch number has been requested.  Follow-up (07Jul2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.
she received her first dose of the Pfizer COVID-19 vaccine on 23Mar2021 and last Wednesday she tested positive for COVID-19; she received her first dose of the Pfizer COVID-19 vaccine on 23Mar2021 and last Wednesday she tested positive for COVID-19; This is a spontaneous report from a contactable consumer (patient) via Pfizer-sponsored program COVAX US Support. A 49-Year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: EN6207), via an unspecified route of administration in upper left arm on 23Mar2021 at 13:15at single dose for COVID-19 immunization. Patient took covid vaccine because she was immunocompromised and wanted to get vaccinated. The patient had medical history of immunocompromisation. The patient did not received other vaccine in four weeks. Concomitant medications were not reported. the patient had unspecified chronic medical condition. On 05Apr2021, patient tested positive for COVID-19 and got result on Wednesday 07Apr2021.The patient stated she has a chronic medical condition but that is does not effect weather or not she tested positive. Her second dose is scheduled for tomorrow, 13Apr2021, however her healthcare professional told her to wait for 10 days after the symptoms subside. She wants clarification on whether or not she will need to restart the vaccination series if she reschedules her second dose for a later date. It was further reported that her doctor that since her quarantine period is not up tomorrow she was told to wait until her 14 day quarantine is over to get her second dose which is 2 or 3 days more. Patient asked will this effect her getting it a few days late or will she have to start the process over. The patient also stated that her mother tested positive for COVID-19 after being vaccinated with the Pfizer COVID-19 vaccine and this happened about a month after her second dose. The patient states that she filed a report for herself, however, she did not file an official report for her mother. She did confirm that she told DSU about her mother's AE. The patient asks when should I test for COVID-19 again to make sure I'm negative? I have upcoming tests that I have to complete and they require me to have a negative COVID-19 test before I can complete them. The patient further states, I guess your vaccine is not providing as much protection as you thought since my mom got COVID after being fully vaccinated with the Pfizer Covid vaccine for a month. Patient declined to provide email address as she is not good at checking it. The outcome of the events was unknown.